Trial Profile
A trial of CERC 501 in treatment of cocaine addition
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 16 Mar 2017
Price :
$35
*
At a glance
- Drugs Aticaprant (Primary)
- Indications Cocaine-related disorders
- Focus Therapeutic Use
- 14 May 2016 According to Cerecor Inc media release, this study is being conducted at Rockefeller University Hospital with funding from a private foundation.
- 30 Mar 2016 New trial record